Genetic risk scores of psychiatric phenotypes are associated with depression risk in a prospective Dutch population-based cohort
Open Access
- 29 September 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e288
Abstract
Background: Genetic risk scores hold potential for predicting depression in the general population. These scores must be validated for their associations with relevant characteristics of depression-related phenotypes, such as severity. We validated a genome-wide risk score (GRS) and a restricted polygenic risk score (PRS) for depression based on a meta-analysis of three genome-wide association studies and assessed their associations with depression in three subcohorts of middle-aged and older adults from the Dutch population-based Rotterdam Study. Methods: Of participants with genotype data, 9,198 had longitudinally measured data (mean follow-up: 11.3 years) on three depression-related phenotypes (depressive symptoms, depressive syndrome, and major depressive disorder). Generalized linear models estimated the associations of standardized GRS and PRS with depression phenotypes per subcohort and were then meta-analyzed. One unit of the GRS/PRS represents 1 standard deviation, following z-transformation per cohort. Results: A one unit higher GRS and PRS were associated with any longitudinally measured depression phenotype (odds ratio (OR)GRS = 1.20 [1.15–1.26], ORPRS = 1.10 [1.05–1.16]). Effect sizes were highest for episodes of major depressive disorder: for individuals with the 10% highest GRS and PRS, the ORs were 1.99 [1.53–2.57] and 1.51 [1.13–1.99], respectively, compared to the middle 50% of the distribution. Conclusions: The GRS and PRS for depression showed modest associations across multiple depression-related phenotypes in a population-based setting. The strength of associations generally increased with the severity of the phenotype. While effect sizes were generally larger for GRS compared to PRS, the difference was mostly not statistically significant.Keywords
Funding Information
- Erasmus Medisch Centrum
- Erasmus Universiteit Rotterdam
- ZonMw
- Ministerie van Onderwijs, Cultuur en Wetenschap
- Ministerie van Volksgezondheid, Welzijn en Sport
- European Commission (DG XII)
This publication has 42 references indexed in Scilit:
- The Rotterdam Study. Design update and major findings between 2020 and 2024European Journal of Epidemiology, 2024
- Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of DepressionJAMA Psychiatry, 2021
- Polygenic Liability and Recurrence of Depression in Patients With First-Onset Depression Treated in Hospital-Based SettingsJAMA Psychiatry, 2021
- Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging diseaseEuropean Journal of Epidemiology, 2021
- Could Polygenic Risk Scores Be Useful in Psychiatry?JAMA Psychiatry, 2021
- From Basic Science to Clinical Application of Polygenic Risk ScoresJAMA Psychiatry, 2021
- Transdiagnostic clinical staging in youth mental health: a first international consensus statementWorld Psychiatry, 2020
- Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish PopulationJAMA Psychiatry, 2019
- Incidence and Recurrence of Late-Life DepressionArchives of General Psychiatry, 2008
- The Center for Epidemiologic Studies Depression scale (CES‐D) in a mixed‐mode repeated measurements design: sex and age effects in older adultsInternational Journal of Methods in Psychiatric Research, 1999